MESSINA, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 171
NA - Nord America 164
AS - Asia 131
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 473
Nazione #
US - Stati Uniti d'America 162
CN - Cina 86
SE - Svezia 74
IT - Italia 37
SG - Singapore 35
RU - Federazione Russa 32
IE - Irlanda 9
FI - Finlandia 6
DE - Germania 4
TR - Turchia 4
AU - Australia 3
DK - Danimarca 3
CA - Canada 2
CO - Colombia 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
LT - Lituania 2
EU - Europa 1
FR - Francia 1
GH - Ghana 1
IN - India 1
KG - Kirghizistan 1
KR - Corea 1
NL - Olanda 1
TW - Taiwan 1
Totale 473
Città #
Shanghai 35
Singapore 26
Boardman 21
New York 18
Ashburn 13
Lawrence 13
Princeton 13
Dublin 9
Milan 9
Rome 9
Florence 5
Guangzhou 5
Helsinki 5
Moscow 5
Dallas 4
Marostica 4
Ankara 3
Beijing 3
Copenhagen 3
Seattle 3
St Petersburg 3
Bogotá 2
Camarillo 2
Hong Kong 2
Hunnebostrand 2
Jiaxing 2
Melbourne 2
Minneapolis 2
Prague 2
San Cipriano d'Aversa 2
Weitang 2
Xi'an 2
Amsterdam 1
Bishkek 1
Chelles 1
Fiesole 1
Foshan 1
Frankfurt am Main 1
Gangseo-gu 1
Genova 1
Lappeenranta 1
Lincoln 1
Los Angeles 1
Munich 1
Newark 1
Ottawa 1
Perm 1
Pizzighettone 1
Pune 1
Santa Clara 1
Shenzhen 1
Shijiazhuang 1
St Louis 1
Sydney 1
Taizhou 1
Totale 254
Nome #
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 37
Alterations of brain structural MRI are associated with outcome of surgical treatment in trigeminal neuralgia 33
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study 30
Tension-type headache 28
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 25
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 23
Imaging the brain and vascular reactions to headache treatments: a systematic review 21
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 21
Neural correlates of visuospatial processing in migraine: does the pain network help? 20
An update on migraine: current understanding and future directions 20
Candesartan in migraine prevention: results from a retrospective real-world study 19
Stress in paediatric migraine: a trigger factor? 19
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 18
Editorial: Functional and Structural Brain Alterations in Headache: A Trait or a State? 18
DIFFERENCES IN BRAIN STRUCTURE AND FUNCTION IN PRIMARY HEADACHE DISORDERS: A MULTIMODAL MRI STUDY 17
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 16
Tracking the evolution of non-headache symptoms through the migraine attack 16
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularization 16
Pathophysiological Bases of Comorbidity in Migraine 16
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 16
Insights into migraine attacks from neuroimaging 14
Clinical correlates of hypothalamic functional changes in migraine patients 14
What We Gain From Machine Learning Studies in Headache Patients 13
CGRP – a target for acute therapy in migraine: Clinical data 13
Editorial: Still Searching for the Origin of Migraine: From Comorbidities to Chronicization 12
Functional MRI in migraine 12
Author response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study 10
What imaging has revealed about migraine and chronic migraine 6
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study 6
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study 5
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study 4
Totale 538
Categoria #
all - tutte 6.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 1 0 0
2020/20219 0 0 3 0 0 4 0 0 0 0 2 0
2021/202222 0 1 1 4 0 4 5 1 1 1 2 2
2022/2023131 31 28 13 1 7 19 6 14 2 0 7 3
2023/2024221 6 10 27 17 40 25 7 32 5 5 14 33
2024/2025154 54 20 22 19 39 0 0 0 0 0 0 0
Totale 538